Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

The 1+Million Genomes Minimal Dataset for Cancer

Defining minimal standards for data collection is key to creating interoperative, searchable genomic and clinical databases. We highlight here the 1+Million Genomes Minimal Dataset for Cancer, encompassing 140 items in 8 domains to foster the collection of cancer data, inform transnational cooperation and advance precision cancer medicine.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The 1+MG-MDC structure.

Data availability

The 1+MG-MDC is maintained in Zenodo (https://doi.org/10.5281/zenodo.10784601)16.

References

  1. Mardis, E. R. Nat. Cancer 2, 1263–1264 (2021).

    Article  CAS  PubMed  Google Scholar 

  2. Jiang, P. et al. Nat. Rev. Cancer 22, 625–639 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sweeney, S. M. et al. Cancer Res. 83, 1175–1182 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. The Clinical Cancer Genome Task Team of the Global Alliance for Genomics and Health. N. Engl. J. Med. 376, 2006–2009 (2017).

    Article  Google Scholar 

  5. Casaletto, J., Bernier, A., McDougall, R. & Cline, M. S. Annu. Rev. Genom. Hum. Genet. 24, 347–368 (2023).

    Article  CAS  Google Scholar 

  6. Riba, M. et al. Preprint at bioRxiv https://doi.org/10.1101/2023.10.07.561259 (2023).

  7. Belenkaya, R. et al. JCO Clin. Cancer Inform. 5, 12–20 (2021).

    Article  PubMed  Google Scholar 

  8. Grossman, R. L. et al. N. Engl. J. Med. 375, 1109–1112 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Guérin, J. et al. JCO Clin. Cancer Inform. 5, 256–265 (2021).

    Article  PubMed  Google Scholar 

  10. The International Cancer Genome Consortium. Nature 464, 993–998 (2010).

    Article  PubMed Central  Google Scholar 

  11. Osterman, T. J., Terry, M. & Miller, R. S. JCO Clin. Cancer Inform. 4, 993–1001 (2020).

    Article  PubMed  Google Scholar 

  12. Zhang, J. et al. Nat. Biotechnol. 37, 367–369 (2019).

    Article  CAS  PubMed  Google Scholar 

  13. Zhang, Z. et al. Nat. Commun. 12, 1226 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Whalley, J. et al. Nat. Commun. 11, 5040 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Tsimberidou, A. M. et al. Nat. Rev. Clin. Oncol. 20, 843–863 (2023).

    Article  PubMed  Google Scholar 

  16. Riba, M. et al. Zenodo https://doi.org/10.5281/zenodo.10784601 (2024).

Download references

Acknowledgements

We wish to thank the 1+MG WG9 community for helpful comments and discussion, as well as the members of the Center for Omics Sciences, at the San Raffaele Scientific Institute in Milan. The B1MG project has received funding from the EU Horizon 2020 research and innovation program under grant agreement no. 951724. The GDI project receives funding from the EU Digital Europe program under grant agreement no. 01081813. This work was also supported by the CCM 2021 ‘Italian Genomics Strategy: establishment of a steering committee to support the European initiative 1+MG and Beyond 1+MG (B1MG) and the Inter-institutional Coordination for Genomics in Public Health’ project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanni Tonon.

Ethics declarations

Competing interests

R.R. has received honoraria from AbbVie, AstraZeneca, Janssen, Illumina, and Roche. G.T. has received honoraria from Janssen, Adaptive Biotechnologies and Diasorin. The other authors do not report competing interests.

Peer review

Peer review information

Nature Genetics thanks Andrew Biankin and George Vassiliou for their contribution to the peer review of this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Riba, M., Sala, C., Culhane, A.C. et al. The 1+Million Genomes Minimal Dataset for Cancer. Nat Genet 56, 733–736 (2024). https://doi.org/10.1038/s41588-024-01721-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-024-01721-x

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer